Found: 11
Select item for more details and to access through your institution.
The regulation and deregulation of Wnt signaling by PARK genes in health and disease.
- Published in:
- Journal of Molecular Cell Biology, 2014, v. 6, n. 1, p. 3, doi. 10.1093/jmcb/mjt037
- By:
- Publication type:
- Article
Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-43820-4
- By:
- Publication type:
- Article
LRRK2: an éminence grise of Wnt-mediated neurogenesis?
- Published in:
- Frontiers in Cellular Neuroscience, 2013, v. 7, p. 1, doi. 10.3389/fncel.2013.00082
- By:
- Publication type:
- Article
Building Bridges In Neuropharmacology: New therapeutic approaches for psychiatric and neurodegenerative disorders.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1478, doi. 10.1111/bph.15575
- By:
- Publication type:
- Article
LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 22, p. 4966, doi. 10.1093/hmg/dds342
- By:
- Publication type:
- Article
L'RRK de Triomphe: a solution for LRRK2 GTPase activity?
- Published in:
- Biochemical Society Transactions, 2016, v. 44, n. 6, p. 1625, doi. 10.1042/BST20160240
- By:
- Publication type:
- Article
The importance of Wnt signalling for neurodegeneration in Parkinson's disease.
- Published in:
- Biochemical Society Transactions, 2012, v. 40, n. 5, p. 1123, doi. 10.1042/BST20120122
- By:
- Publication type:
- Article
Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.
- Published in:
- Molecular Neurodegeneration, 2017, v. 12, p. 1, doi. 10.1186/s13024-017-0153-4
- By:
- Publication type:
- Article
Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity.
- Published in:
- Frontiers in Molecular Neuroscience, 2016, p. 1, doi. 10.3389/fnmol.2016.00018
- By:
- Publication type:
- Article
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same.
- Published in:
- Molecular Neurodegeneration, 2019, v. 14, n. 1, p. 1, doi. 10.1186/s13024-019-0344-2
- By:
- Publication type:
- Article